Nicolas Galmarini

Building the future of biological therapies through precision, execution, and scale. I am the Co-Founder and CEO of Nanogrow Biotech, where I lead a multidisciplinary team developing next-generation biologics for oncology and immune-mediated diseases.Our work is built around Nanobody (VHH) technology, combining biological discovery, engineering, formulation, and product development to create precise, versatile, and accessible therapeutic solutions.With operations in Uruguay and Spain, we bring together scientific excellence, agility, and capital efficiency with international development standards. Through a B2B model based on strategic partnerships, co-development, and licensing, we build differentiated biological assets and connect them with the right industry partners.My background combines economics, finance, and management with more than 15 years of experience in the pharmaceutical and biotechnology industries. I have worked across business development, international licensing, complex negotiations, biological innovation, and company building.One of my main strengths is translating science into business: turning promising scientific opportunities into structured development programs, valuable partnerships, and scalable business models, with a strong focus on execution.I believe world-class science can be created anywhere, but its true value is realized when it reaches the world. At Nanogrow, we are building the capabilities and partnerships needed to transform biological innovation into the therapies of the future.